Penobscot Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Penobscot Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Sell	1,518 -2	-0.1%	-$344	0.02%	272
2026 Q1	$257K	Hold	1,520	–	–	0.02%	285
2025 Q4	$257K	Hold	1,520	–	–	0.02%	283
2025 Q3	$219K	Buy	+1,520	New	+$207K	0.02%	303
2025 Q1	–	Sell	-1,565	Closed	-$207K	–	305
2024 Q4	$207K	Sell	1,565 -105	-6%	-$14.8K	0.02%	295
2024 Q3	$243K	Hold	1,670	–	–	0.02%	289
2024 Q2	$229K	Hold	1,670	–	–	0.02%	284
2024 Q1	$229K	Buy	1,670 +150	+10%	+$20.5K	0.02%	281
2023 Q4	$206K	Buy	+1,520	New	+$185K	0.02%	288
2016 Q1	–	Sell	-1,824	Closed	-$206K	–	183
2015 Q4	$206K	Buy	+1,824	New	+$198K	0.06%	185

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Penobscot Investment Management's IBB Position: Q2 2026 in Review

Penobscot Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 0.13% in Q2 2026, selling an estimated $344 and leaving 1,518 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #272.

Penobscot Investment Management first reported a position in IBB in Q4 2015 and has held it in 10 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Penobscot Investment Management held 1,518 shares of iShares Biotechnology ETF worth $289K as of Q2 2026.
Penobscot Investment Management sold 2 iShares Biotechnology ETF shares in Q2 2026, an estimated $344.
iShares Biotechnology ETF made up 0.02% of Penobscot Investment Management's portfolio in Q2 2026, its #272 holding.
Penobscot Investment Management first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 10 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.